Post-transcriptional modification of RNA nucleosides occurs in all living organisms. Pseudouridine, the most abundant modified nucleoside in non-coding RNAs 1 , enhances the function of transfer RNA and ribosomal RNA by stabilizing the RNA structure [2][3][4][5][6][7][8] . Messenger RNAs were not known to contain pseudouridine, but artificial pseudouridylation dramatically affects mRNA function-it changes the genetic code by facilitating non-canonical base pairing in the ribosome decoding centre 9,10 . However, without evidence of naturally occurring mRNA pseudouridylation, its physiological relevance was unclear.
, enhances the function of transfer RNA and ribosomal RNA by stabilizing the RNA structure [2] [3] [4] [5] [6] [7] [8] . Messenger RNAs were not known to contain pseudouridine, but artificial pseudouridylation dramatically affects mRNA function-it changes the genetic code by facilitating non-canonical base pairing in the ribosome decoding centre 9, 10 . However, without evidence of naturally occurring mRNA pseudouridylation, its physiological relevance was unclear.
Here we present a comprehensive analysis of pseudouridylation in Saccharomyces cerevisiae and human RNAs using Pseudo-seq, a genomewide, single-nucleotide-resolution method for pseudouridine identification. Pseudo-seq accurately identifies known modification sites as well as many novel sites in non-coding RNAs, and reveals hundreds of pseudouridylated sites in mRNAs. Genetic analysis allowed us to assign most of the new modification sites to one of seven conserved pseudouridine synthases, Pus1-4, 6, 7 and 9. Notably, the majority of pseudouridines in mRNA are regulated in response to environmental signals, such as nutrient deprivation in yeast and serum starvation in human cells. These results suggest a mechanism for the rapid and regulated rewiring of the genetic code through inducible mRNA modifications. Our findings reveal unanticipated roles for pseudouridylation and provide a resource for identifying the targets of pseudouridine synthases implicated in human disease [11] [12] [13] . Although more than 100 classes of RNA modifications have been characterized, primarily in tRNA and rRNA 14 , only three modified nucleotides have been identified within the coding sequences of mRNA, N 6 -methyladenosine (m 6 A), 5-methylcytosine (m 5 C) and inosine [15] [16] [17] [18] [19] . To define the global landscape of RNA pseudouridylation in vivo and determine whether mRNAs contain pseudouridine (Y), we developed a high-throughput method to identify Y in the transcriptome with single-nucleotide resolution. Y can be selectively modified with N-cyclohexyl-N9-(2-morpholinoethyl)-carbodiimide metho-p-toluenesulphonate (CMC) to generate a block to reverse transcriptase one nucleotide 39 to the pseudouridylated site 20 . We exploited this chemistry to determine the locations of Y using nextgeneration sequencing ( Fig. 1a ; see Methods). Mock-treated (2CMC) RNA fragments were processed in parallel to identify pseudouridineindependent reverse transcription stops.
Using Pseudo-seq and stringent Y-calling criteria, we identified 42/51 known Ys in rRNA and small nuclear RNA (Supplementary Table 1) with an observed false positive rate of 0.1%. The estimated false discovery rate (FDR) ranges from approximately 5% for highly expressed genes 1 Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. to approximately 12.5% for lowly expressed genes. (Fig. 1b-d and Methods). Six out of nine false negatives were due to 'shadowing' from reverse transcription stops 39 of the Y (for example, 25S-Y2258 was not detected upstream of Y2260). We also identified many Ys in tRNA, all of which occurred at known positions (Supplementary Table 2) . We verified the single-nucleotide resolution of Pseudo-seq by profiling four small nucleolar RNA deletion mutants that eliminate pseudouridylation of nine specific rRNA and snRNA target sites (Extended Data Fig.  1a-d) . Similar specificity and sensitivity were achieved using different reverse transcription enzymes, RNA fragment lengths, CMC concentrations, and truncated cDNA lengths, demonstrating the robustness of the Pseudo-seq method (Extended Data Fig. 2a-d) .
After validating the ability of Pseudo-seq to detect known Ys in noncoding RNAs, we next analysed mRNA pseudouridylation in budding yeast during post-diauxic growth (A 600 nm 5 12) (Extended Data Fig. 3a) . To define high confidence Pseudo-seq hits even in transcripts with sparse read coverage, we required reproducibility in 10/14 independent experiments (Extended Data Fig. 3b, c) . Notably, we found that many mRNAs contain Y (Fig. 2a) . In total, we conservatively identified 260 Ys in 238 protein-coding transcripts (Supplementary Table 3 ). Relaxing our criteria to include Ys detected in 9/14 experiments, a category that includes the known Y56 in U2 snRNA, increased the number of candidate mRNA Ys to 466. We established a rough detectability threshold by determining the lowest observed expression level of genes having sufficient reads for reproducible Y calling; 5,278 genes passed the cutoff. Thus, it is unlikely that there are substantially more mRNA Ys to be discovered in postdiauxic yeast. We conclude that mRNA pseudouridines are relatively scarce. Ys were found in 59 transcript leaders (59TLs), coding sequences (CDS), and 39 untranslated regions (39 UTRs) with an underrepresentation of Y in 39 UTRs (P 5 10
24
, hypergeometric test) (Fig. 2b) . GUA valine codons were the most frequently modified, suggesting the existence of a sequence-specific mechanism for mRNA pseudouridylation (Extended Data Fig. 4) .
We investigated the potential for regulation of mRNA pseudouridylation by comparing two cellular conditions with substantial differences in gene expression and physiology: log phase and post-diauxic growth. Remarkably, most mRNA Ys were regulated: 42% of the sites modified during post-diauxic growth were not detectably modified in log phase, whereas other sites, such as CDC33 Y286, were much more extensively modified during exponential growth. Moreover, of the 150 modified sites detected in both log phase and post-diauxic growth, 62 showed .twofold changes in peak height between conditions indicating growthstate-dependent changes in the extent of mRNA modification ( Fig. 2a and Supplementary Table 3) . Importantly, we ruled out differences in mRNA expression as an explanation for condition-dependent differences in Y detection (Extended Data Fig. 5) . Thus, the process of mRNA pseudouridylation is regulated in response to environmental cues.
Yeast non-coding RNAs (ncRNA) have been extensively characterized for post-transcriptional modifications. Nevertheless, we identified 74 novel pseudouridylated sites in ncRNAs (Supplementary Table 4 ). A few, like Y274 in the RNase MRP RNA (NME1) (Fig. 2c) , were constitutively modified, while most, including the previously described Y56 and Y93 in U2 snRNA 21 , were induced during post-diauxic growth (Extended Data Fig. 6a ). snoRNAs were notably enriched among ncRNA classes with regulated pseudouridines: 19/29 H/ACA and 14/47 C/D snoRNAs showed one or more sites specifically modified in cells grown to high density (Fig. 2d, Extended Data Fig. 6b, c) . Pseudouridylation of rRNA sites changed very little: only one site, 25S-Y2314, changed more than twofold. However, owing to the stability of rRNA and the greatly reduced rate of ribosome synthesis during post-diauxic growth, we cannot rule out production of a minority population of differentially modified ribosomes in dense cultures.
We next sought to define the molecular basis for targeting of novel mRNA and ncRNA sites for pseudouridylation. Ys in rRNA, snRNA and tRNA are produced by two classes of enzymes with distinct modes of target recognition. The first class, which includes yeast Cbf5 and human dyskerin, associates with H/ACA snoRNAs to direct pseudouridylation of sites that base pair with the snoRNA guide sequences, while the second class recognizes its targets without the aid of an RNA guide. We computationally identified 157 unique sites in mRNAs containing perfect matches to canonical snoRNA targets (Supplementary Table 5 ). When these potential pseudouridylation sites were considered in aggregate, statistically significant pseudouridylation was detected ( 
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for Y calling on their own (Extended Data Fig. 7e ). Thus, it is probable that many additional mRNAs are pseudouridylated at a low level and our estimate of 260 mRNA Ys represents a conservative minimum. Because most pseudouridylated sites showed no significant complementarity to snoRNA guide sequences, we next investigated whether snoRNAindependent pseudouridine synthases are responsible for modifying sites in mRNAs. Yeast has nine pseudouridine synthase (PUS) genes, all of which are expressed in both log phase and post-diauxic growth. We profiled the eight viable PUS deletion strains (pusD) grown to high density and identified mRNA targets for each Pus protein, with the exception of Pus5 whose only known target is the 21S mitochondrial rRNA 22 ( Fig Table 6 ). The largest number of mRNA and novel ncRNA Ys could be assigned to Pus1, a member of the TruA family that constitutively modifies multiple positions in cytoplasmic tRNAs and one position in U2 snRNA by a mode of target recognition that is incompletely defined. Whereas known Pus1-dependent tRNA targets showed constitutive pseudouridylation as expected, most of the mRNA targets showed increased modification during post-diauxic growth (Extended Data Fig. 8c , Supplementary Table 3 ). The mRNA targets of Pus1 showed little similarity at the primary sequence level, consistent with the proposed structuredependent mode of target recognition by this enzyme (Fig. 3c, Extended  Data Fig. 8d) 
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, while Pus2, a close paralogue of Pus1, had 14 mRNA targets with a weak sequence consensus distinct from Pus1 (Fig. 3d,  Extended Data Fig. 8e) . Intriguingly, the Pus1 targets included seven genes encoding five proteins of the large ribosomal subunit, a significant enrichment (P 5 0.025). Our comprehensive pseudouridine profiling more than doubles the number of known substrates of Pus1 and Pus2, identifies unanticipated mRNA targets, and provides the first demonstration of regulated pseudouridylation by these enzymes.
Unlike Pus1 and Pus2, the mRNA targets of Pus4 and Pus7 contained clear consensus sites in agreement with the known sequence requirements for these enzymes to modify their canonical tRNA targets, UGYAR for Pus7 and GUYCNANNC for Pus4 (Fig. 3e-g Fig. 8f-h ) 24, 25 . We also identified novel targets for Pus3 (20 mRNA, 1 ncRNA), Pus6 (3, 1) and Pus9 (1, 0), and, in total, assigned 52% of mRNA Ys and 31% of novel ncRNA Ys to individual Pus proteins. The remaining sites may be modified by the essential protein Pus8 and/or may be redundantly targeted by multiple Pus proteins. Together, these results reveal unanticipated diversity in Pus targets and show that Pus-dependent non-tRNA sites are regulated in response to changing cellular growth conditions. The discovery of novel mRNA substrates for Pus proteins raises the possibility that other tRNA modifying enzymes may likewise target mRNAs.
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As the pseudouridine synthases that modify yeast mRNAs are conserved throughout eukaryotes, we investigated whether regulated mRNA pseudouridylation also occurs in mammalian cells. Human cervical carcinoma (HeLa) cells were profiled during normal proliferation and 24 h after serum starvation. Pseudo-seq detected known pseudouridines with good sensitivity and specificity (Supplementary Table 7 , Extended Data Fig. 9a-c) . By restricting our analysis to more highly expressed genes and requiring reproducibility in four independent biological replicates, we conservatively identified 96 Ys in 89 human mRNAs (Supplementary Table 8 ). As in yeast, some Y modifications in human mRNAs were regulated by cellular growth state (Fig. 4a, Extended Data Fig. 10a, b) , and modified sites were found throughout the transcript (Fig. 4b) . We also discovered novel Ys in human ncRNAs, including 4 previously unknown sites in rRNA (Extended Data Fig. 10c , Supplementary Table 9) and sites in long non-coding (lnc-), sn-and snoRNAs (Fig. 4c, d) . Thus, the Pseudo-seq approach is broadly applicable to diverse organisms and growth states. Moreover, the phenomenon of regulated mRNA pseudouridylation is conserved from yeast to humans.
In summary, Pseudo-seq provides comprehensive analysis of RNA pseudouridylation with single-nucleotide resolution and reveals that endogenous mRNAs are specifically pseudouridylated in a highly regulated manner in yeast and human cells. Because Y stabilizes RNA structure, mRNA pseudouridylation could alter translation initiation efficiency 26, 27 , ribosome pausing 28 , RNA localization 29 and regulation by RNA interference 30 , to name a few aspects of mRNA metabolism known to be affected by RNA structure, although we cannot exclude the possibility that many instances of mRNA pseudouridylation may be functionally silent. However, given recent evidence that pseudouridine profoundly affects decoding by ribosomes from diverse organisms 9 , our results also raise the possibility of widespread regulated rewiring of the genetic code. Finally, this work suggests that diseases associated with mutations in pseudouridine synthases, including mitochondrial myopathy and sideroblastic anaemia (MLASA) 11 , dyskeratosis congenita 12 and lung cancer 13 , could be due to misregulation of mRNA targets.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
METHODS
Yeast strains and growth. All yeast strains are Saccharomyces cerevisiae BY4741 or BY4742 derivatives (BY4742: wild type (YWG11), snr37D (YWG287, YWG343), pus9D (YWG1215) ). The snoRNA deletion strains and pus4D strains were made using PCR-based deletion cassettes 31 . The other pusD strains were obtained from the Yeast Deletion Collection 32 . Strains were grown at 30 uC in YPAD (1% yeast extract, 2% peptone, 0.01% adenine hemisulphate, 2% glucose), and were harvested by centrifugation in log phase (A 600 nm < 1), or at high density (A 600 nm < 12-15). Cell culture. HeLa (human cervix adenocarcinoma; CCL-2, ATCC) cells were cultured in DMEM (D6429; Sigma) supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals). Cells were grown at 37 uC with 5% CO 2 under standard laboratory conditions. For serum starvation cells were plated at a density of 5 3 10 6 per 150-mm plate in DMEM110% FBS, 24 h before the experiment. Cells were then washed three times in PBS, before the addition of either serum-free medium (DMEM, no FBS) or full medium containing FBS (DMEM110% FBS) for 24 h. Pseudo-seq library preparation. Yeast total RNA was isolated by hot acid phenol extraction, followed by isopropanol precipitation 33 . HeLa total RNA was isolated using QIAzol (Qiagen; 79306). PolyA1 RNA was isolated from 10 mg (yeast) or 2 mg (HeLa) total RNA using oligo dT cellulose beads (NEB; S1408S), as described 34 . For some libraries, two sequential rounds of polyA selection were performed. Yeast RNA was fragmented in 10 mM ZnCl 2 at 94 uC for 5 min (total RNA) or 55 s (polyA1 RNA), and HeLa RNA was fragmented in 10 mM ZnAcetate at 60 uC for 10 min. Fragmented RNA was then precipitated.
CMC treatment of RNA fragments was as follows 20 . RNA was denatured in 5 mM EDTA at 80 uC for 2 min, and then placed on ice. 0.5 M CMC in BEU buffer (7 M urea, 4 mM EDTA, 50 mM bicine, pH 8.5) was added to a final concentration of 0.2 or 0.4 M CMC (43 RNA volume). CMC modification was carried out at 40 uC for 30 min, followed by ethanol precipitation. Subsequent reversal of modification of Us and Gs was carried out in NaCO 3 buffer (50 mM sodium-carbonate, pH 10.4, 2 mM EDTA) at 50 uC for 2 h, followed by precipitation. In parallel mocktreated samples were incubated in BEU buffer without CMC.
RNA fragments were dephosphorylated with CIP (NEB; M0290) and PNK (NEB; M0201), followed by size selection and elution of 80-100, 100-120, and 120-140-nt fragments on an 8% urea-TBE polyacrylamide gel electrophoresis (PAGE) gel, followed by precipitation. RNA fragments were eluted from gel slices overnight at 4 uC with gentle rocking in 400 ml RNA elution buffer (300 mM NaOAc pH 5.5, 1 mM EDTA, 100 U ml 21 RNasin (Promega; N2615)). Ligation of a pre-adenylated 39 adaptor (IDT; /5Phos/TGGAATTCTCGGGTGCCAAGG/3ddC/) was carried out with T4 RNA ligase (NEB; M0204) in 13 buffer without ATP (50 mM Tris-HCl, pH 7.8, 10 mM MgCl 2 , 10 mM DTT) at 22 uC for 2.5 h, followed by precipitation.
Reverse transcription (RT) was carried out using AMV-RT (Promega; M5108) with the following conditions. The reverse transcription primer (IDT; /5Phos/GAT CGTCGGACTGTAGAACTCTGAACCTGTCGGTGGTCGCCGTATCATT/iSp18/ CACTCA/iSp18/GCCTTGGCACCCGAGAATTCCA) and RNA were denatured and annealed in reverse transcription buffer (50 mM Tris-Cl pH 8.6, 60 mM NaCl, 10 mM DTT). After annealing, dNTPs (3.3 mM each final) and MgCl 2 (6 mM final) were added, and reverse transcription was carried out at 42 uC for 1 h. Truncated cDNAs were size-selected and purified on an 8% urea-TBE PAGE gel, followed by precipitation. cDNAs were eluted from gel slices overnight at room temperature with gentle rocking in 400 ml DNA elution buffer (300 mM NaCl, 10 mM Tris, pH 8.0). cDNAs were circularized with circLigase (Epicentre; CL4115K), and amplified by PCR with Phusion (NEB; M0530) with the forward primer (IDT; AATGATAC GGCGACCACCGA), and a barcoded reverse primer (IDT; CAAGCAGAAGAC GGCATACGAGATXXXXXXGTGACTGGAGTTCCTTGGCACCCGAGAATT CCA). PCR products were gel-purified, precipitated and sequenced on an Illumina HiSeq 2000. Sequencing data analysis. RNA-seq data was analysed with in-house Bash and Python scripts unless otherwise specified. For yeast libraries, adaptor sequences were trimmed using Cutadapt 35 , and were subsequently mapped to the S. cerevisiae genome downloaded from the Saccharomyces Genome Database (SGD) on 9/2/ 2011. Mapping to the genome and defined splice junctions (UCSC, sacCer3) was performed using Tophat2 36 . Multiply mapping reads were allowed. Using SAMtools to exclude multiply mapping reads affected Ys called in repetitive or paralogous features, but not Ys identified in other features 37 .
Trimmed reads from HeLa libraries were mapped with Bowtie1 allowing up to 2 mismatches to a database of spliced transcripts (hg19 sequence, and transcripts downloaded from UCSC on 1 August 2012) containing the transcript with the longest coding sequence, or the longest transcript for non-coding genes 38 . Multiply mapping reads were allowed for generation of receiver operating characteristic curves and MetaPsi plots, but were excluded for Y predictions. Identification of Y. The yeast transcriptome (downloaded from SGD on 9 February 2011) with annotated 59 and 39 UTRs was used to identify new sites of pseudouridylation 39 . Where annotated 59 and 39 UTRs were not available, median UTR lengths were used. To identify new sites of pseudouridylation in HeLa cells the human transcriptome described above was used. For a given 1/2CMC library pair, the 2CMC libraries were first scaled to the size of the 1CMC libraries. Peak values were calculated for each position 1 nt 39 of a U (peak position) in all features with an average per nucleotide read coverage greater than a specified read cutoff:
Where r 1 and r 2 indicate the number of reads whose 59 ends map to the position being examined in the 1CMC and -CMC libraries, respectively, wr 1 and wr 2 represent the numbers of reads whose 59 ends map to a window centred at the position being examined (exclusive of reads at that position), and ws specifies the size of this window (exclusive of that position). Sites with peak positions greater than a specified peak cutoff were flagged as potential Y. To filter out false positives reproducibility of peak calling in a certain number of libraries was required.
Window size (ws) was set to 150 for all analyses. Only features surpassing an average reads/nt threshold (read cutoff) were considered. For high density yeast, the read cutoff was set to 0.0, the peak cutoff was set to 1.0, and reproducibility was required in 10 of 14 libraries. For log phase yeast, the peak values from log phase data were calculated for the high density identified Y. For both serum fed and serum starved HeLa cells, the read cutoff was set to 1.0, the peak cutoff was set to 2.0, and reproducibility was required in 4 of 4 libraries. A subset of called Y in HeLa cells came from very narrow (,20 nt) regions of uniquely mapping reads. These calls were considered unreliable and were removed. MetaPsi plots and ROC curves. For a given Y, the reads at each position in a 51-nt window centred at the Y were normalized to the average reads per nucleotide within the window. These windows of normalized reads were then averaged for all known Y in yeast rRNA and U2 or human rRNA and snRNA, yielding a metaPsi. Given the close spacing of Y in these features, the number of Y at each position in the metaPsi window was also plotted.
To generate receiver operating characteristic (ROC) curves for a given 1/2CMC library pair, the 2CMC libraries were first scaled to the size of the 1CMC libraries, and peak values were calculated (see above) for each position 1 nt 39 of a U or Y in the features above. Additionally, a 2CMC peak value was determined: peak {~w s| r { wr z zwr { Parameters are as defined earlier. A range of 10,000 equally spaced cutoff scores were chosen spanning the range of observed peak values. At each cutoff score, the true positive and false positive rates were calculated, and plotted. Estimation of false discovery rate. The lower bound for FDR was estimated from the observed FDR for the rRNA. The upper bound of FDR for lowly expressed genes was estimated by randomly down-sampling reads in the rRNA and U2 snRNA to a level of coverage comparable to that of lowly expressed mRNAs with Ys. These randomizations were performed 14 times followed by Y calling on down-sampled libraries as described above. This number should be considered a rough estimate because the ribosomal RNA may not provide a perfect basis for estimating the FDR of Y calling in mRNA. The observed number of false positives in the rRNA and snRNA under the criteria used to call Ys in mRNA was two incorrect Y calls in 1905 U residues (0.1%).
Defining Y regulation and factor-dependence. To determine if a given Y was condition dependent the median peak values between two conditions were compared. For yeast only wild-type peak values were included. A twofold or greater change between conditions was considered regulated.
Ys were identified as Pus-dependent if the peak heights in both biological replicates of a given pusD strain were less than 25% of the median peak height for that Y across all libraries. For a given Y to be considered PUS-dependent, we required at least one replicate for a given pusD strain to have sufficient reads in the 150-nt window surrounding the Y to be greater than 25% of the median reads in that window for all libraries. snoRNA target site predictions and analysis. To identify potential sites of pseudouridylation within yeast mRNAs, the yeast transcriptome (described above) was scanned for sites that perfectly match the known target sequences of all yeast Box H/ACA snoRNAs, allowing mismatches at bases that are unpaired in known target sites 40 .
For the analysis presented in Extended Data Fig. 7a, b, 10 ,000 randomizations were performed. For each trial, a random U was chosen for each non-repetitive computationally predicted snoRNA target, and was matched to the same gene, and RESEARCH LETTER
